Status:
UNKNOWN
Study of the Compliance With Phosphorus Restricted Diet and Phosphate Binder Therapy in Hemodialysis Patients
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hyperphosphatemia is a common and severe complication in chronic kidney disease patients treated with hemodialysis. A phosphate restricted diet and oral phosphate binders are the cornerstones in the p...
Eligibility Criteria
Inclusion
- prevalent (\>3months) hemodialysis patients
- aged \> 18 years
- informed consent
Exclusion
- decreased consciousness
- unstable
- medical contraindication for phosphorus restricted diet or phsophate binder therapy
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2012
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01509027
Start Date
January 1 2012
End Date
June 1 2012
Last Update
May 30 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Leuven
Leuven, Belgium, 3000